The oncologic efficacy of extended resections for lung cancer
- PMID: 36630100
- DOI: 10.1002/jso.27183
The oncologic efficacy of extended resections for lung cancer
Abstract
Extended lung resections for T3-T4 non-small-cell lung cancer remain challenging. Multimodal management is mandatory in multidisciplinary tumor boards, and here the determination of resectability is key. Long-term oncologic efficacy depends mostly on complete resection (R0) and the extent of N2 disease. The development of novel innovative treatments (targeted therapy and immune checkpoint inhibitors) sets interesting perspectives to reinforce current therapeutic options in the induction and adjuvant setting.
Keywords: extended resections; locally advanced lung cancer; multimodal treatment; non-small-cell lung cancer; resectability; surgery.
© 2023 Wiley Periodicals LLC.
References
REFERENCES
-
- Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39-51. doi:10.1016/j.jtho.2015.09.009
-
- Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth edition lung cancer stage classification. Chest. 2017;151(1):193-203. doi:10.1016/j.chest.2016.10.010
-
- Daly ME, Singh N, Ismaila N, et al. Management of stage III non-small-cell lung cancer: ASCO guideline. J Clin Oncol. 2022;40(12):1356-1384. doi:10.1200/JCO.21.02528
-
- NCC Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer 2022. Accessed November 13th, 2022. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf
-
- NCC Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer 2021. August 18, 2021. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
